Accent Therapeutics

Developing RNA-modifying protein therapeutics for cancer with significant unmet medical need

placeLexington, Massachusetts, United States calendar_todayFounded 2017 groups45 employees language accenttx.com

Registered entities

Social engagement

Social engagement: 6.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include EcoR1, Atlas Venture, The Column Group.

Investor typeCountShare
Venture capital542%
Other / undisclosed758%

Recent activity

29 May 2026
Event
American Chemical Society National Medicinal Chemistry Symposium
21 May 2026
Event
2026 American Society of Clinical Oncology (ASCO) Annual Meeting
17 Apr 2026
Event
AACR26 poster session
Coming soon